pI: 4.3381 |
Length (AA): 588 |
MW (Da): 64450 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 68 | 2fcf (A) | 1162 | 1240 | 20.00 | 0.000014 | 0.49 | 0.39 | -0.39 |
9 | 216 | 4rey (A) | 13 | 207 | 24.00 | 0 | 1 | 0.603141 | -0.04 |
9 | 201 | 3rle (A) | 13 | 192 | 31.00 | 0 | 1 | 0.657031 | -0.13 |
448 | 571 | 2y44 (A) | 58 | 187 | 10.00 | 0.79 | 0.03 | 0.305284 | -0.36 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intraerythrocytic - 36 hs, intraerythrocytic - 40 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 24 hs, intraerythrocytic - 30 hs, intraerythrocytic - 48 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intraerythrocytic - 18 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_128083)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_IV007640 | hypothetical protein |
Brugia malayi | Bm1_55675 | GRASP55/65 family protein |
Brugia malayi | Bm1_54125 | golgi reassembly stacking protein 2 |
Candida albicans | CaO19.71 | weak similarity to S. cerevisiae GRH1 (YDR517W) GRASP Homolog, Golgi-localized spindle checkpoint protein |
Caenorhabditis elegans | CELE_Y42H9AR.1 | Protein Y42H9AR.1 |
Cryptosporidium hominis | Chro.70047 | Golgi reassembly stacking protein 2, possibly N-myristoylated (53.7 kD) (4I879) |
Cryptosporidium parvum | cgd7_340 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0293248 | golgi reassembly stacking protein |
Drosophila melanogaster | Dmel_CG7809 | CG7809 gene product from transcript CG7809-RA |
Echinococcus granulosus | EgrG_000181900 | Golgi reassembly stacking protein 2 |
Echinococcus multilocularis | EmuJ_000181900 | Golgi reassembly stacking protein 2 |
Homo sapiens | ENSG00000115806 | golgi reassembly stacking protein 2, 55kDa |
Homo sapiens | ENSG00000114745 | golgi reassembly stacking protein 1, 65kDa |
Leishmania braziliensis | LbrM.33.2660 | Golgi reassembly stacking protein (GRASP homologue), putative |
Leishmania donovani | LdBPK_332510.1 | Golgi reassembly stacking protein (GRASP homologue), putative |
Leishmania infantum | LinJ.33.2510 | Golgi reassembly stacking protein (GRASP homologue), putative |
Leishmania major | LmjF.33.2380 | Golgi reassembly stacking protein (GRASP homologue), putative |
Leishmania mexicana | LmxM.32.2380 | Golgi reassembly stacking protein (GRASP homologue), putative |
Loa Loa (eye worm) | LOAG_07938 | golgi reassembly stacking protein 2 |
Mus musculus | ENSMUSG00000014959 | golgi reassembly stacking protein 2 |
Mus musculus | ENSMUSG00000032513 | golgi reassembly stacking protein 1 |
Neospora caninum | NCLIV_025630 | gorasp2-prov protein, putative |
Onchocerca volvulus | OVOC160 | Putative golgi reassembly stacking protein |
Plasmodium berghei | PBANKA_0501600 | golgi re-assembly stacking protein, putative |
Plasmodium falciparum | PF3D7_1017300 | golgi re-assembly stacking protein 1, golgi re-assembly stacking protein 2 |
Plasmodium knowlesi | PKNH_0601500 | golgi re-assembly stacking protein, putative |
Plasmodium vivax | PVX_001735 | golgi re-assembly stacking protein, putative |
Plasmodium yoelii | PY00200 | similar to golgi perepheral membrane protein p65, putative |
Saccharomyces cerevisiae | YDR517W | Grh1p |
Schistosoma japonicum | Sjp_0035410 | Golgi reassembly-stacking protein 2, putative |
Schistosoma mansoni | Smp_169990.1 | golgi reassembly stacking protein 2 (grasp2) |
Schistosoma mansoni | Smp_169990.2 | golgi reassembly stacking protein 2 (grasp2) |
Schmidtea mediterranea | mk4.007473.01 | |
Schmidtea mediterranea | mk4.006667.01 | |
Trypanosoma brucei gambiense | Tbg972.11.2920 | Golgi reassembly stacking protein (GRASP homologue), putative |
Trypanosoma brucei | Tb927.11.2660 | Golgi reassembly stacking protein (GRASP homologue), putative |
Trypanosoma congolense | TcIL3000_0_24440 | Golgi reassembly stacking protein (GRASP homologue), putative |
Trypanosoma congolense | TcIL3000.11.2410 | Golgi reassembly stacking protein (GRASP homologue), putative |
Trypanosoma cruzi | TcCLB.506301.20 | Golgi reassembly stacking protein (GRASP homologue), putative |
Trypanosoma cruzi | TcCLB.504153.320 | Golgi reassembly stacking protein (GRASP homologue), putative |
Toxoplasma gondii | TGME49_261980 | gorasp2-prov protein |
Theileria parva | TP03_0249 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.0260 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.0260 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.0260 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.0260 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_261980 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.